Talk:Telithromycin
From Wikipedia, the free encyclopedia
[edit] Questions of telithromycin safety under public and congressional scrutiny
I propose moving this section to come after the "side effects" section.--Gak 15:04, 13 September 2006 (UTC)
- Why? That's not as logical a proposal as it appears on the surface. It's a controversy not only about side effects, but refers to reports that reveal questions of the telithromycin's indications and impact on marketing status (product inserts have already been changed), not to mention it reveals FDA in-fighting and disparate current medical opinion about the drug. It's a current event or series of events. If anything, bring the side effects section up to complement that section. The "Questions" section needs to be prominently displayed where it is at a top level of hierarchy in the article because of its immediate import to public health, and not relegated to dissappear in "side effects" section at the bottom of the page. That would mitigate its impact as a current event. Regardless, we need to rename "Side effects" to "Adverse effects" since that is what's used across the industry and on other wiki pages. For example, see the variations of article structure on controversial drugs here: Vioxx, Celebrex, Nexium, proton pump inhibitor, Crestor, statins, selective serotonin reuptake inhibitor. Piewalker 17:30, 13 September 2006 (UTC)
